LONDON (Reuters), Aug 21 - Cancer survival is improving in Europe, but Britain and Denmark are lagging, with lower rates than countries that spend the same amount on health care, according to two new studies published on Tuesday.
The latest Eurocare studies -- which include data from 83 cancer registries in 23 countries -- also suggest that wide differences in survival rates among countries are narrowing.
"Increases in survival and decreases in geographic differences over time, which are mainly due to improvements in health-care services in countries with poor survival, might indicate better cancer care," Italian researcher Franco Berrino and colleagues wrote in the Lancet Oncology.
Survival for the four most common cancers -- colorectal, lung, breast and prostate -- and ovarian cancer was best in central Europe and most Nordic states. South Europe was in the middle, followed by Britain and Ireland and then eastern Europe.
The researchers, using data on 2.7 million cancer patients, said if all countries had the mean survival rate of 57 percent of Norway, Sweden, and Finland, there would be about 150,000 -- or 12% -- fewer deaths in the five years after diagnosis.
They also mostly found, as expected, the more a country spent on health care, the better its survival rates, except for in Britain and Denmark.
In Britain, the five-year survival rate was about 42% for men and 52% for women, versus the European average of about 45% and 55%, respectively.
Western Europe scored just a few percentage points higher than eastern European states Slovenia, Poland, and the Czech Republic, despite spending far more on healthcare -- a factor researchers attributed to late diagnoses and poor care.
"If survival in one country is substantially lower than that in other countries, especially those of a similar wealth, the health system is probably not functioning as it should," the researchers wrote.
Arduino Verdecchia, from Rome's Istituo Superiore di Santia, found similar results in a related study and said Europeans diagnosed with cancer had a bleaker outlook than U.S. sufferers.
The five-year survival rate in the U.S. was 66% in men and 63% in women, versus 47% and 56%, respectively, in Europe, he and colleagues wrote. They suggested better skills and training of U.S. health workers and investment in facilities and other treatment services there might explain the difference.
By Michael Kahn
Last Updated: 2007-08-21 10:00:46 -0400 (Reuters Health)
Related Reading
UK cancer death rate falls 12 percent - scientists, February 4, 2004
Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
